2021
DOI: 10.1016/j.biopha.2020.111093
|View full text |Cite
|
Sign up to set email alerts
|

Deleted in lymphocytic leukemia 2 (DLEU2): An lncRNA with dissimilar roles in different cancers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
14
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(14 citation statements)
references
References 18 publications
0
14
0
Order By: Relevance
“…Furthermore, among our top predicted proliferation/growth inducers were the lncRNAs DLEU2, TMPO-AS1 , and MIR17HG . DLEU2 has been verified as a proliferation-inducing lncRNA in the vast majority of cancer types (13 out of 16) ( Ghafouri-Fard et al, 2021 ), and TMPO-AS1 has a role in tumorigenesis and progression and is overexpressed in 15 different cancer types ( Zheng et al, 2021 ). The lncRNA MIR17HG is the host gene of the miR-17–92 cluster, which consists of a group of onco-microRNAs that induce pan-cancer cell proliferation/growth ( Mogilyansky and Rigoutsos, 2013 ).…”
Section: Resultsmentioning
confidence: 99%
“…Furthermore, among our top predicted proliferation/growth inducers were the lncRNAs DLEU2, TMPO-AS1 , and MIR17HG . DLEU2 has been verified as a proliferation-inducing lncRNA in the vast majority of cancer types (13 out of 16) ( Ghafouri-Fard et al, 2021 ), and TMPO-AS1 has a role in tumorigenesis and progression and is overexpressed in 15 different cancer types ( Zheng et al, 2021 ). The lncRNA MIR17HG is the host gene of the miR-17–92 cluster, which consists of a group of onco-microRNAs that induce pan-cancer cell proliferation/growth ( Mogilyansky and Rigoutsos, 2013 ).…”
Section: Resultsmentioning
confidence: 99%
“…Another study reported that LOC541471 is a novel prognostic biomarker for head and neck squamous cell carcinoma [ 38 ]. The leukaemia 2 gene (DLEU2) has been reported to play an important role in a variety of diseases [ 39 , 40 ], especially in tumour diseases, including thyroid cancer, gastric cancer, sarcopenia, and laryngeal squamous cell carcinoma, and has been shown to play a role through the ceRNA mechanism [ 41 – 44 ].…”
Section: Resultsmentioning
confidence: 99%
“…Furthermore, among our top predicted proliferation/growth inducers were the lncRNAs DLEU2 , TMPO-AS1 , and MIR17HG . DLEU2 has been verified as a proliferation-inducing lncRNA in the vast majority of cancer types (13 out of 16) (Ghafouri-Fard, Dashti, Farsi, & Taheri, 2021), and TMPO-AS1 has a role in tumorigenesis and progression and is overexpressed in 15 different cancer types(Zheng et al, 2021). The lncRNA MIR17HG is the host gene of the miR-17-92 cluster, which consists of a group of onco- microRNAs that induce pan-cancer cell proliferation/growth(Mogilyansky & Rigoutsos, 2013).…”
Section: Resultsmentioning
confidence: 99%